ThrombusCheck

Palo Alto, United States Founded: 2017 • Age: 9 yrs
Offers a device that mimics plaqued arteries for personalized anti-platelet therapy.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 6 Brand Intelligence

About ThrombusCheck

ThrombusCheck is a company based in Palo Alto (United States) founded in 2017. It operates as a B2B. ThrombusCheck operates in a competitive market with competitors including Accumetrics, AggreDYNE, Zabit Pharmaceutical, COC Pharmaceuticals Industry and DCM Pharmaceutical Industry, among others.

  • Headquarter Palo Alto, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of ThrombusCheck

Premium access

Detailed funding history for ThrombusCheck

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by ThrombusCheck

Investments
Premium access

Investment portfolio details for ThrombusCheck

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - ThrombusCheck

Premium access

Detailed financials for ThrombusCheck

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Thrombuscheck Comparisons

ThrombusCheck Primary company
Description
Offers a device that mimics plaqued arteries for personalize...
Location
Palo Alto, United States
Founded Year
2017
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for ThrombusCheck

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of ThrombusCheck

ThrombusCheck operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Accumetrics, AggreDYNE, Zabit Pharmaceutical, COC Pharmaceuticals Industry and DCM Pharmaceutical Industry, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Platelet function assays and coagulation systems are developed and marketed.
Locked Locked Locked
Platelet stickiness is measured using patented Aggreguide A-100.
Locked Locked Locked
Develops innovative devices for platelet functioning tests.
Locked Locked Locked
Develops diagnostic devices for platelet function analysis.
Locked Locked Locked
Creates innovative diagnostic devices for measuring platelet dysfunction in healthcare.
Premium access

Detailed competitors of ThrombusCheck

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Thrombuscheck

Premium access

Complete news archive for ThrombusCheck

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ThrombusCheck

ThrombusCheck was founded in 2017.

ThrombusCheck is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.

ThrombusCheck offers a device that mimics plaqued arteries for personalized anti-platelet therapy, focusing on providing healthcare solutions, developing medical devices, diagnostic tools, and cardiovascular therapy. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.

ThrombusCheck's top competitors include Accumetrics, AggreDYNE and Zabit Pharmaceutical.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available